Direct‐acting antivirals for chronic hepatitis C

BACKGROUND: Millions of people worldwide suffer from hepatitis C, which can lead to severe liver disease, liver cancer, and death. Direct‐acting antivirals (DAAs), e.g. sofosbuvir, are relatively new and expensive interventions for chronic hepatitis C, and preliminary results suggest that DAAs may e...

Full description

Saved in:
Bibliographic Details
Published in:Cochrane Database Syst Rev
Main Authors: Jakobsen, Janus C, Nielsen, Emil Eik, Feinberg, Joshua, Katakam, Kiran Kumar, Fobian, Kristina, Hauser, Goran, Poropat, Goran, Djurisic, Snezana, Weiss, Karl Heinz, Bjelakovic, Milica, Bjelakovic, Goran, Klingenberg, Sarah Louise, Liu, Jian Ping, Nikolova, Dimitrinka, Koretz, Ronald L, Gluud, Christian
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Ltd 2017
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6484376/
https://ncbi.nlm.nih.gov/pubmed/28922704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012143.pub3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items